Observations on the clinical and pathologic aspects of the pelvic congestion syndrome

Stearns, Howard C.; Sneeden, Vinton D.

doi:10.1016/0002-9378(66)90404-2

Cited by 15 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although extensive literature on the diagnosis and the treatment of PCS exists, [10][11][12][13][14][15][16][17][18][19] studies of 56 women who underwent OV embolization are currently published or in press from 1993 to the present. [20][21][22][23][24][25] With follow-up ranging from 6 to 15.4 months, relief varied from "cure" to no change or a worsening of the symptoms.…”

Section: Discussionmentioning

confidence: 99%

Pelvic congestion syndrome: Early clinical results after transcatheter ovarian vein embolization

Cordts

Eclavea²,

Buckley³

et al. 1998

Journal of Vascular Surgery

114

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Pelvic congestion syndrome: Early clinical results after transcatheter ovarian vein embolization

Cordts

Eclavea²,

Buckley³

et al. 1998

Journal of Vascular Surgery

114

View full text Add to dashboard Cite

show abstract

“…The difference between the toxicity against HaCaT and NHDF cells might be due to the protective effect of fibroblasts provided by its high collagen contents, which help them to maintain the structure of the dermal layer. [ 54 ] Bright‐field images showed a strong detachment of cells, rounding, and shrinkage in both cell lines (example for NHDF cells is shown in Figure S8, Supporting Information, indicating apoptosis).…”

Section: Resultsmentioning

confidence: 99%

Inhibition of Collagenase Q1 of Bacillus cereus as a Novel Antivirulence Strategy for the Treatment of Skin‐Wound Infections

Alhayek

Khan

Schönauer

et al. 2022

Advanced Therapeutics

View full text Add to dashboard Cite

Despite the progress in surgical techniques and antibiotic prophylaxis, opportunistic wound infections with Bacillus cereus remain a public health problem. Secreted toxins are one of the main factors contributing to B. cereus pathogenicity. A promising strategy to treat such infections is to target these toxins and not the bacteria. Although the exoenzymes produced by B. cereus are thoroughly investigated, little is known about the role of B. cereus collagenases in wound infections. In this report, the collagenolytic activity of secreted collagenases (Col) is characterized in the B. cereus culture supernatant (csn) and its isolated recombinantly produced ColQ1 is characterized. The data reveals that ColQ1 causes damage on dermal collagen (COL). This results in gaps in the tissue, which might facilitate the spread of bacteria. The importance of B. cereus collagenases is also demonstrated in disease promotion using two inhibitors. Compound 2 shows high efficacy in peptidolytic, gelatinolytic, and COL degradation assays. It also preserves the fibrillar COLs in skin tissue challenged with ColQ1, as well as the viability of skin cells treated with B. cereus csn. A Galleria mellonella model highlights the significance of collagenase inhibition in vivo.

show abstract

“…The extracellular membrane (ECM) generates fibroblasts, which are responsible for maintaining skin integrity and elasticity in the dermis area. Therefore, alterations and degradation of the ECM during dermal thinning can cause increased numbers of wrinkles and decreased skin elasticity [26].…”

Section: Characteristic Of Aging Skinmentioning

confidence: 99%

The Impact of Herbal Products in the Prevention, Regeneration and Delay of Skin Aging

Warsito

Kusumawati

2019

Advances in Experimental Medicine and Biology

View full text Add to dashboard Cite

Advances in Experimental Medicine and Biology presents multidisciplinary and dynamic findings in the broad fields of experimental medicine and biology. The wide variety in topics it presents offers readers multiple perspectives on a variety of disciplines including neuroscience, microbiology, immunology, biochemistry, biomedical engineering and cancer research. Advances in Experimental Medicine and Biology has been publishing exceptional works in the field for over 30 years and is indexed in Medline, Scopus, EMBASE, BIOSIS, Biological Abstracts, CSA, Biological Sciences and Living Resources (ASFA-1), and Biological Sciences. The series also provides scientists with up-to-date information on emerging topics and techniques. 2018 Impact Factor: 2.126 Content of this series is reviewed.

show abstract

Observations on the clinical and pathologic aspects of the pelvic congestion syndrome

Cited by 15 publications

References 18 publications

Pelvic congestion syndrome: Early clinical results after transcatheter ovarian vein embolization

Pelvic congestion syndrome: Early clinical results after transcatheter ovarian vein embolization

Inhibition of Collagenase Q1 of Bacillus cereus as a Novel Antivirulence Strategy for the Treatment of Skin‐Wound Infections

The Impact of Herbal Products in the Prevention, Regeneration and Delay of Skin Aging

Contact Info

Product

Resources

About